Nature Communications publication: A new type of specialized epithelial subtype of cells may hold the key to overcoming resistance to prostate cancer treatments
A team of scientists has made a groundbreaking discovery that could explain why certain prostate cancer therapies are less effective than expected. With 5,000 Norwegian men diagnosed with the disease annually, resulting in roughly 1,000 deaths every year, a major clinical objective is to prevent the spread of cancer and recurrence.
The study was published in Nature Communications November 16th. Alfonso Urbanucci from the Institute of Cancer Research is shared senior author.
